We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The vaccine is contraindicated in children with a history of severe allergic reactions to a previous dose of Vaxelis, any ingredient in the drug, or similar vaccines. Read More
The committee recommended granting marketing authorization for Shionogi's Mulpleta (lusutrombopag), for the treatment of severe thrombocytopenia in adults with chronic liver disease undergoing invasive procedures. Read More
The approval clears Keytruda for marketing in all 28 EU member states as well as Iceland, Lichtenstein and Norway. The drug is also approved in Europe as a monotherapy for advanced melanoma in adults. Read More